1.
Clinical and Experimental Study of Gan Bing San Hao on Chronical Virus B Hepatitis in Protecting Liver and Reducing the Enzym in Serum;
关于肝病3号保肝降酶作用的临床观察及实验研究
2.
Therapeutic Observatin on Effects of NO.3 Baogan Decoction Through Colon Administration on 60 Cases of Chronic Viral Hepatitis B
保肝3号汤结肠给药治疗慢性乙型病毒性肝炎60例疗效观察
3.
The Clinic Research on Treatment of Chronic Heptitis B by Gan Bin Ⅰ;
肝病Ⅰ号治疗慢性乙型病毒性肝炎的临床研究
4.
A Clinical Study of TCM Zhi Mi Tong Ⅲ in the Treatment of Constipation Due to Stagnated Liver Qi;
痔秘通3号治疗肝郁气滞型便秘的临床观察
5.
Approximately one third of all patients with malignant disease have hepatic metastasis.
在有恶性病变的全部病人中，大约1／3有肝转移。
6.
GENETIC ANALYSIS OF RESISTANCE OF WHEAT LINE BEI MIAN 3 TO ERYSIPHE GRAMINIS F. SP. TRITICI
白免3号小麦抗白粉病遗传初步分析
7.
Kangmai 3 Capsule Treats Diabetes Foot Clinical Research;
康脉3号胶囊治疗糖尿病足临床研究
8.
The Clinic and Experiment Study on the Effect of Hepato-protection by Colon-drip Medication with Hepatoprotection-3 Decoction;
保肝3号汤剂结肠给药保肝作用的临床观察及实验研究
9.
Clinical Research on Parkinson s Disease No.3;
帕病3号方治疗帕金森病的临床疗效观察
10.
STUDIES ON DISEASES RESISTANCE IN RICE BREEDING Ⅰ.Blast resistance of ken rice and the release of Zhong-dan No. 1 No. 2 and No. 3
水稻抗病育种研究 Ⅰ.粳稻的抗瘟性和中丹1号、2号、3号的育成
11.
Three of 68 patients had not shown any obstructive pathological lesions.
仍有3例未能显示出肝外胆管梗阻病变。
12.
The Role of Toll-like Receptor 3 in Apoptosis of Bewo Cells Induced by Hepatitis B Virus
Toll样受体3在乙肝病毒致bewo细胞凋亡中的作用
13.
Expression and Relation of Capase-3 and TNF-α in Alcoholic Liver Disease Rats
Caspase-3和TNF-α在大鼠酒精性肝病中的表达及意义
14.
Expression and clinical significance of Glypican-3 protein in benign and malignant disease of the liver
Glypican-3在肝脏良恶性病变中的表达及临床意义
15.
Clinical study of ω-3 fatty acids in patients after resection operation of liver cancer
肝癌切除术后病人ω-3脂肪乳的应用研究
16.
Expression of TNF-α,Caspase-3 in apoptosis of alcoholic liver disease rats
TNF-α、Caspase-3在大鼠酒精性肝病细胞凋亡中的表达
17.
Expressions of Caspase-3、NF-κB in rars with alcoholic liver disease rats
大鼠酒精性肝病细胞凋亡中Caspase-3、NF-κB的表达
18.
SOCS-3 Expression in the Liver of NAFLD Rat Model and the Intervention Study of Rosiglitazone;
非酒精性脂肪肝病大鼠肝脏SOCS-3的表达和罗格列酮干预研究